Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 453.75 million compared to CNY 407.25 million a year ago. Revenue was CNY 453.75 million compared to CNY 407.25 million a year ago.

Net income was CNY 89.31 million compared to CNY 76.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.66 compared to CNY 0.569 a year ago. Diluted earnings per share from continuing operations was CNY 0.66 compared to CNY 0.569 a year ago.